Publication | Closed Access

Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure

Heart FailureChronic Heart FailureCardiovascular DiseaseMedicineVascular PharmacologyPhysiologyCardiovascular PharmacologyVascular BiologyCardiovascular PhysiologyCardiovascular FunctionPharmacologyCardiologyAcute Type 5Phosphodiesterase Inhibition